Ji-Hong Hong - Search Results

Year	Number of Results
2002	3
2003	6
2004	6
2005	5
2006	5
2007	7
2008	5
2009	5
2010	6
2011	7
2012	11
2013	9
2014	1
2015	4
2016	8
2017	9
2018	10
2019	8
2020	9
2021	6
2023	1
2024	2

1

A Comprehensive Review on Current Advances in Peptide Drug Development and Design.

Lee AC, Harris JL, Khanna KK, Hong JH. Lee AC, et al. Among authors: hong jh. Int J Mol Sci. 2019 May 14;20(10):2383. doi: 10.3390/ijms20102383. Int J Mol Sci. 2019. PMID: 31091705 Free PMC article. Review.

2

A sense of danger from radiation.

McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M, Liao YP. McBride WH, et al. Among authors: hong jh. Radiat Res. 2004 Jul;162(1):1-19. doi: 10.1667/rr3196. Radiat Res. 2004. PMID: 15222781 Review.

3

What are the potential benefits of using proton therapy in Taiwanese cancer patients?

Kao WH, Shen YL, Hong JH. Kao WH, et al. Among authors: hong jh. Biomed J. 2015 Sep-Oct;38(5):391-8. doi: 10.4103/2319-4170.153211. Biomed J. 2015. PMID: 25768324 Free article. Review.

4

MOSFET dose measurements for proton SOBP beam.

Hsing CH, Oanh LDH, Chao TC, Lee CC, Hong JH, Cheng CC, Tseng CK, Tung CJ. Hsing CH, et al. Among authors: hong jh. Phys Med. 2021 Jan;81:185-190. doi: 10.1016/j.ejmp.2020.12.007. Epub 2021 Jan 16. Phys Med. 2021. PMID: 33465755

5

Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.

Hsieh RC, Lee CH, Huang HC, Wu SW, Chou CY, Hung SP, Lee CW, Krishnan S, Venkatesulu BP, Lee JC, Chou YC, Chan KM, Lin PT, Lee WC, Lin CC, Lin SY, Hong JH. Hsieh RC, et al. Among authors: hong jh. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):712-724. doi: 10.1016/j.ijrobp.2023.09.049. Epub 2023 Sep 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 37778426

6

Persistent Fatigue in Patients With Hepatocellular Carcinoma Receiving Radiotherapy.

Chen CY, Huang BS, Hong JH, Chang JT, Chen MC, Tang WR, Shun SC, Chen ML. Chen CY, et al. Among authors: hong jh. J Nurs Res. 2024 Apr 1;32(2):e319. doi: 10.1097/jnr.0000000000000606. J Nurs Res. 2024. PMID: 38506576

7

Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.

Hung SP, Huang BS, Hsieh CE, Lee CH, Tsang NM, Chang JT, Chen JS, Chou WC, Tseng JH, Hong JH. Hung SP, et al. Among authors: hong jh. Am J Clin Oncol. 2020 Mar;43(3):180-186. doi: 10.1097/COC.0000000000000646. Am J Clin Oncol. 2020. PMID: 31764017

8

Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.

Lee AC, Shih YY, Zhou F, Chao TC, Lee H, Liao YF, Hsu WM, Hong JH. Lee AC, et al. Among authors: hong jh. J Mol Med (Berl). 2019 Mar;97(3):325-339. doi: 10.1007/s00109-018-1730-x. Epub 2019 Jan 5. J Mol Med (Berl). 2019. PMID: 30612140

9

High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.

Chang CN, Chen WC, Wei KC, Ng SH, Ho YS, Huang DY, Lee SP, Hong JH. Chang CN, et al. Among authors: hong jh. J Neurooncol. 2003 Jan;61(1):45-55. doi: 10.1023/a:1021270201988. J Neurooncol. 2003. PMID: 12587795 Review.

10

Sunitinib Treatment-elicited Distinct Tumor Microenvironment Dramatically Compensated the Reduction of Myeloid-derived Suppressor Cells.

Fu SY, Wang CC, Chen FH, Yu CF, Hong JH, Chiang CS. Fu SY, et al. Among authors: hong jh. In Vivo. 2020 May-Jun;34(3):1141-1152. doi: 10.21873/invivo.11886. In Vivo. 2020. PMID: 32354903 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year